A detailed history of Gables Capital Management Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gables Capital Management Inc. holds 200 shares of BDX stock, worth $44,396. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$44,396
Previous $46,000 4.35%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$254.9 - $283.59 $2,549 - $2,835
-10 Reduced 4.76%
200 $51,000
Q1 2023

May 03, 2023

BUY
$229.71 - $259.35 $2,297 - $2,593
10 Added 5.0%
210 $51,000
Q4 2020

Feb 03, 2021

SELL
$221.92 - $245.94 $4,438 - $4,918
-20 Reduced 9.09%
200 $50,000
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $43,154 - $55,352
200 Added 1000.0%
220 $51,000
Q2 2018

Aug 03, 2018

BUY
$208.1 - $233.85 $4,162 - $4,677
20 New
20 $5,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.